Cite
HARVARD Citation
Schmidt-Kraepelin, C. et al. (2022). Amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia in Germany (COMBINE): a double-blind randomised controlled trial. Lancet. pp. 291-306. [Online].